Literature DB >> 11509190

Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac.

A H Söderpalm1, A Schuster, H de Wit.   

Abstract

Although the public debate about the legalization of marijuana has continued for as long as 25 years, few controlled studies have been conducted to assess its potential medical benefits. The present study examined the antiemetic effect of smoked marijuana cigarettes (8.4 and 16.9 mg Delta(9)-tetrahydrocannabinol [THC]) compared to a highly potent antiemetic drug, ondansetron (8 mg) in 13 healthy volunteers. Nausea and emesis were induced by syrup of ipecac. Marijuana significantly reduced ratings of "queasiness" and slightly reduced the incidence of vomiting compared to placebo. Ondansetron completely eliminated the emetic effects of ipecac. These findings support and extend previous results, indicating that smoked marijuana reduces feelings of nausea and also reduces emesis in this model. However, its effects are very modest relative to ondansetron, and the psychoactive effects of marijuana are likely to limit its clinical usefulness in the general population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509190     DOI: 10.1016/s0091-3057(01)00533-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

Review 1.  Medical and recreational marijuana: commentary and review of the literature.

Authors:  Samuel T Wilkinson
Journal:  Mo Med       Date:  2013 Nov-Dec

2.  Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ⁹-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive-compulsive behaviour.

Authors:  Serena Deiana; Akihito Watanabe; Yuki Yamasaki; Naoki Amada; Marlene Arthur; Shona Fleming; Hilary Woodcock; Patricia Dorward; Barbara Pigliacampo; Steve Close; Bettina Platt; Gernot Riedel
Journal:  Psychopharmacology (Berl)       Date:  2011-07-28       Impact factor: 4.530

Review 3.  Endocannabinoids and the gastrointestinal tract: what are the key questions?

Authors:  G J Sanger
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

Review 4.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Medical marijuana initiatives : are they justified? How successful are they likely to be?

Authors:  Wayne Hall; Louisa Degenhardt
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).

Authors:  Magdalena Kwiatkowska; Linda A Parker; Page Burton; Raphael Mechoulam
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

Review 7.  [Review of cannabinoids in the treatment of nausea and vomiting].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2004-08       Impact factor: 1.107

8.  Consequences of alcohol and marijuana use among college students: Prevalence rates and attributions to substance-specific versus simultaneous use.

Authors:  Kristina M Jackson; Alexander W Sokolovsky; Rachel L Gunn; Helene R White
Journal:  Psychol Addict Behav       Date:  2020-01-16

9.  Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.

Authors:  Eric P Baron; Philippe Lucas; Joshua Eades; Olivia Hogue
Journal:  J Headache Pain       Date:  2018-05-24       Impact factor: 7.277

Review 10.  A Review of Cannabis in Chronic Kidney Disease Symptom Management.

Authors:  Claudia Ho; Dan Martinusen; Clifford Lo
Journal:  Can J Kidney Health Dis       Date:  2019-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.